echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Pfizer/BioNTech submits third shot of new crown vaccine marketing application

    Pfizer/BioNTech submits third shot of new crown vaccine marketing application

    • Last Update: 2021-09-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    news

    news

    On August 17, Pfizer/Bio-Entech submitted to the FDA the early data of the third injection of the new crown vaccine market application


    Drug source analysis

    Drug source analysis

    The main reason for facilitating the submission of this application is the emergence of the delta strain


    One reason is that although the existing vaccination has limited protection against delta infection after a period of time, the protection against severe illness and death is still very effective, which is still more than 80%


    Pfizer/Bio-Entai's Phase I data show that the third injection increased the delta neutralizing antibody titer by about 100 times, but whether this can be translated into clinical benefits remains to be proven


    The new crown is a global pandemic and may also require a global strategy


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.